Johnson & Johnson (JNJ) Shares Issued (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Shares Issued came in at $1.2 billion in Q1 2026, up 160.44% year-on-year from $450.0 million in Q1 2025, and down 26.15% quarter-over-quarter from $1.6 billion in Q4 2025.

Johnson & Johnson (JNJ) Shares Issued (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Shares Issued across 18 years of filings, most recently posting $1.2 billion for Q1 2026.

  • Shares Issued for Q1 2026 came in at $1.2 billion, up 160.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 billion (up 1523.53% YoY), and the FY2025 annual result was $3.4 billion, changed N/A from the prior year.
  • Shares Issued came in at $1.2 billion for Q1 2026 at Johnson & Johnson, down from $1.6 billion in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.3 billion in Q3 2023 to a low of -$3.3 billion in Q4 2023.
  • The 5-year median for Shares Issued is $195.0 million (2024), against an average of $346.5 million.
  • Peak annual rise in Shares Issued reached 1872.73% in 2024, while the deepest fall reached 481.82% in 2024.
  • Johnson & Johnson's Shares Issued stood at $321.0 million in 2022, then sank by 41.74% to $187.0 million in 2023, then tumbled by 481.82% to -$714.0 million in 2024, then surged by 322.27% to $1.6 billion in 2025, then retreated by 26.15% to $1.2 billion in 2026.
  • The last three Shares Issued figures came in at $1.2 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 10.79 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 1.17 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 157.00 Mn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 166.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 1.17 Bn
Mar 29, 2026 1.17 Bn
Dec 28, 2025 1.59 Bn
Dec 28, 2025 1.59 Bn
Sep 28, 2025 1.27 Bn
Sep 28, 2025 1.27 Bn
Jun 29, 2025 107.00 Mn
Jun 29, 2025 107.00 Mn
Mar 30, 2025 450.00 Mn
Mar 30, 2025 450.00 Mn
Dec 29, 2024 -714.00 Mn
Dec 29, 2024 -714.00 Mn
Sep 29, 2024 424.00 Mn
Sep 29, 2024 424.00 Mn
Jun 30, 2024 95.00 Mn
Jun 30, 2024 95.00 Mn
Mar 31, 2024 195.00 Mn
Mar 31, 2024 195.00 Mn
Dec 31, 2023 187.00 Mn
Dec 31, 2023 187.00 Mn